Observational studyInternational journal of clinical oncology2025

Outcomes of capecitabine plus temozolomide combination therapy in patients with advanced or metastatic pancreatic neuroendocrine tumors: a retrospective observational single-center study.

Yukiko Hibino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.